Skip to main content
SpringerLink
Log in

Pfizer-BioNTech COVID-19 vaccination in children: no serious AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ripabelli G, et al. Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy Human Vaccines and Immunotherapeutics : 8 Nov 2022. Available from: URL: https://doi.org/10.1080/21645515.2022.2126668

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfizer-BioNTech COVID-19 vaccination in children: no serious AEs. Reactions Weekly 1932, 12 (2022). https://doi.org/10.1007/s40278-022-27377-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-27377-1

Search

Navigation